Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects

FOR IMMEDIATE RELEASE

Ambry Genetics
15 Argonaut
Aliso Viejo, CA 92656


Aliso Viejo, CA and State College, PA: December 3, 2009 - Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics’ NextGENe® Software for next-generation sequencing projects performed at Ambry Genetics.

Anja Kammesheidt PhD, Ambry’s CSO said, "Our team at Ambry has been providing genomics solutions on Illumina’s® Genome Analyzer platform for 2 years now. In light of diversifying applications, increasing project sizes, and new genomes to be explored, having a proven and innovative partner for bioinformatics is key. While some of our clients are interested in performing their own analyses, others are asking for extended support. We have been impressed with SoftGenetics’ Software tools, as well as their approach to take care of the clients’ needs which is very much in line with Ambry’s philosophy. We are looking forward to working together to provide tailored services to our clients."

Jonathan Liu PhD, SoftGenetics VP Research & Development echoed Dr. Kammesheidt’s thoughts and added that "the SoftGenetics/Ambry partnership provides a new strategic alliance that will not only provide a single streamlined source for next-generation sequencing researchers but will also provide SoftGenetics with a deepened vision of future researcher requirements, allowing NextGENe to remain at the forefront of next-generation sequencing software." "This highly unique alliance", continued John Fosnacht, SoftGenetics VP Sales & Marketing, "provides researchers wishing to utilize the power of next-generation sequencing a distinctive value proposition by combining the technical quality of Ambry Genetics sequencing with the unique analysis capabilities of NextGENe® without the heavy investment typically required in next-generation sequencing instrumentation and bioinformatics. We all believe this is a true win-win situation for everyone."

"Next-generation sequencing services are more valuable to any scientific researcher if you can offer a full menu for bioinformatics support" said Ardy Arianpour, Director of Business Development, Genomic Services at Ambry Genetics. "Ambry Genetics has now become the genomics community’s one-stop service shop for next-generation sequencing services. We can handle large projects and we can offer the most robust data analysis through the exclusive alliance with SoftGenetics. "

Ambry Genetics has been providing next generation sequencing services to pharmaceutical, biotech and academic clients for a wide range of applications including targeted resequencing through custom or exome sequence capture, transcriptome, ChIP and de novo sequencing. Ambry Genetics is focused on delivering the highest quality results with the most sensible workflows while maintaining cost effective contracts for the genomics community.


About SoftGenetics Certified Solution Provider

SoftGenetics, LLC, located in State College Pennsylvania specializes in the development of genetic analysis tools for both research and diagnostic applications. Hallmarks of SoftGenetics software tools are advanced technologies, providing exceptional accuracy, and sensitivity in an easy-to use Windows® user interface. Its NextGENe® software provides biologists with an easy-to-use software analysis tool which improves Next Generation Sequencing accuracy in a complete, freestanding Windows® based program. NextGENe® virtually eliminates bioinformatics requirements, utilizes low cost hardware, and is compatible with all major NGS systems. To learn more, or to request a 30-day trial of the software, please visit: SoftGenetics at www.softgenetics.com.

About Ambry Genetics ®

Ambry Genetics is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy, unparalleled service, and responsibly applying new technologies to the clinical molecular diagnostics market. For more information about Ambry Genetics, visit ambrygen.com.

Press Contact:
Aaron Schmidt
Sr Manager, Communications
aschmidt@ambrygen.com
949 457 4679

Search Results

Start your search...